FIHP patients with MEN1 and CASR mutations are generally younger and have multiglandular disease, whereas patients with CDC73 mutations have a disproportionally high prevalence of PC (Warner et al., 2004; Iacobone et al., 2007). The gene discussed is CASR; the disease is familial isolated hyperparathyroidism.